Aurobindo Pharma gets EIR for Andhra Pradesh manufacturing facility

20 Dec 2023 Evaluate

The United States Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) to Aurobindo Pharma’s wholly owned subsidiary -- APL Healthcare’s Unit IV, a Formulation manufacturing facility situated at Menakuru Village, Naidupeta Mandal, Tirupati District, Andhra Pradesh. The said facility has been classified as Voluntary Action Indicated (VAI). 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1244.70 4.00 (0.32%)
23-Dec-2024 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1812.15
Dr. Reddys Lab 1353.75
Cipla 1474.95
Lupin 2166.65
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.